Skip to main content
Shalby Limited logo

Shalby Limited — Investor Relations & Filings

Ticker · SHALBY ISIN · INE597J01018 LEI · 335800RVKD2F29DRCR78 BSE.NS Human health and social work activities
Open in API
Filings indexed 793 across all filing types
Latest filing 2019-05-27 Call Transcript
Country IN India
Listing BSE.NS SHALBY

About Shalby Limited

https://www.shalby.org

Shalby Limited is a multi-specialty organization recognized for its expertise in orthopedics and joint replacement surgery. The entity operates a network of facilities offering comprehensive medical services, including cardiology, oncology, neurology, and nephrology. It is distinguished by its high volume of orthopedic procedures and the implementation of the "Zero Technique" for knee replacements, designed to minimize surgical duration and accelerate patient recovery. In addition to clinical care, the organization maintains a presence in the orthopedic implant sector through its manufacturing division, which produces specialized implants and surgical instrumentation. The group focuses on providing tertiary and quaternary care utilizing advanced diagnostic and therapeutic infrastructure to serve a diverse patient base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is an invitation to an investor conference call discussing quarterly and full-year financial results (Q4FY19 & FY19). It includes details such as date, time, dial-in numbers, and contact information for RSVP. There is no actual financial data or transcript of the call included, only the announcement of the call event. Therefore, this document is best classified as a Call Transcript (CT) type announcement, specifically an invitation to a conference call. Given the content, the most appropriate classification is Call Transcript (CT).
2019-05-27 English
Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (340 characters) and contains only header information related to stock exchange listing departments and scrip codes. There is no substantive content, financial data, or report details. It appears to be a brief regulatory or listing-related notice without any report or announcement of voting results, dividends, or management changes. Given the lack of detailed content and the nature of the text, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2019-05-27 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation for the Fourth Quarter and year ended 31 March 2019' and is submitted under Regulation 30 of SEBI LODR, indicating it is a presentation to investors. It contains detailed financial and operational performance data, growth drivers, business model, expansion plans, and key achievements. The document is about 15,000 characters long, which is substantial and contains detailed content rather than a brief announcement or a certification. The content is consistent with an investor presentation focusing on financials, strategy, and market position rather than a formal report like an annual or quarterly report or earnings release. Therefore, the appropriate classification is Investor Presentation (IP).
2019-05-27 English
Dividend
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) reporting the outcome of a Board Meeting held on May 25, 2019. It references the approval of audited financial results for the quarter and year ended March 31, 2019, along with the auditors' report, Board's report, Management Discussion and Analysis, and Corporate Governance Report. It also mentions recommendations for dividends, appointments of auditors, and other corporate governance matters. The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates timely disclosure of material events to stock exchanges. The document is not the full annual report or the audited financial statements themselves but an announcement of the board meeting outcomes including approval of these reports. The length is about 6345 characters, which is relatively short and consistent with an announcement rather than the full report. Therefore, this document is best classified as a Regulatory Filing (RNS) since it is a regulatory announcement of board meeting outcomes and financial results approval, not the full Annual Report (10-K) or standalone Audit Report (AR).
2019-05-27 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is a detailed statement regarding the utilization of IPO proceeds as of March 31, 2019, including a monitoring agency report by HDFC Bank Ltd. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 32, which mandates disclosure of utilization of issue proceeds. The document includes financial figures related to IPO proceeds, their utilization, and pending amounts, as well as a monitoring report confirming the use of funds. This is not an announcement of a report but contains substantive financial data and compliance information related to capital raised through an IPO. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2019-05-26 English
Financial Result Updates
Regulatory Filings
2019-05-25 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.